QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.107.129122v1 324/3/911    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Linard, C. Articles by Benderitter, M. PubMed PubMed Citation Articles by Linard, C. Articles by Benderitter, M.

INFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA

Reduction of Peroxisome Proliferation-Activated Receptor Expression by -Irradiation as a Mechanism Contributing to Inflammatory Response in Rat Colon: Modulation by the 5-Aminosalicylic Acid Agonist

Laboratory of Radiopathology, Radiological Protection and Human Health Division, Institute for Radioprotection and Nuclear Safety, Fontenay-aux-Roses, France

Radiation-induced intestinal injuries, including inflammation and immune response, remain a limiting factor in the effectiveness of pelvic radiotherapy and in the patient's quality of life during and after treatment. Peroxisome proliferation-activated receptor (PPAR) agonists are now emerging as therapeutic drugs for various inflammatory diseases that are characterized by impaired PPAR expression. The purpose of this study was to investigate the profile of PPAR expression in rat colonic mucosa 3 and 7 days after abdominal -irradiation (10 Gy). We tested whether irradiation-induced acute inflammatory response could be modulated pharmacologically with the antiinflammatory properties of 5-aminosalicylic acid (5-ASA) (250 mg/kg/day), which is a PPAR activator. Irradiation drastically reduced mRNA and protein levels of PPAR and - and of the heterodimer retinoid X receptor (RXR) at 3 days postirradiation. 5-ASA treatment normalized both PPAR and RXR expression at 3 days postirradiation and PPAR at 7 days. By promoting PPAR expression and its nuclear translocation, 5-ASA interfered with the nuclear factor (NF)-B pathway, both by reducing irradiation-induced NF-B p65 translocation/activation and increasing the expression of nuclear factor-B inhibitor (IB) mRNA and protein. Therefore, 5-ASA prevents irradiation-induced inflammatory processes as well as expression of tumor necrosis factor , monocyte chemotactic protein-1, inducible nitric-oxide synthase, and macrophage infiltration. In addition, 5-ASA restores the interferon /signal transducer and activator of transcription (STAT)-1 and STAT-3 concentrations that were impaired at 3 and 7 days postirradiation and are correlated with suppressor of cytokine signaling-3 repression. Collectively, these results indicate that PPAR agonists may be effective in the prevention of inflammatory processes and immune responses during and after pelvic radiotherapy.

Address correspondence to: Dr. Christine Linard, Institut de Radioprotection et de Sûreté Nucléaire, Direction de la Radioprotection de l'Homme, Laboratoire de Radiopathology, B.P. no. 17, F-92262 Fontenay-aux-Roses Cedex, France. E-mail: christine.linard{at}irsn.fr